The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Open accessThe DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Abstract
Gut microbiota is emerging as a key regulator of many disease conditions and its dysregulation is implicated in the pathogenesis of several gastrointestinal and extraintestinal disorders. More recently, gut microbiome alterations have been linked to neurodegeneration through the increasingly defined gut microbiota brain axis, opening the possibility for new microbiota-based therapeutic options. Although several studies have been conducted to unravel the possible relationship between Alzheimer’s Disease (AD) pathogenesis and progression, the diagnostic and therapeutic potential of approaches aiming at restoring gut microbiota eubiosis remain to be fully addressed. In this narrative review, we briefly summarize the role of gut microbiota homeostasis in brain health and disease, and we present evidence for its dysregulation in AD patients. Based on these observations, we then discuss how dysbiosis might be exploited as a new diagnostic tool in early and advanced disease stages, and we examine the potential of prebiotics, probiotics, fecal microbiota transplantation, and diets as complementary therapeutic interventions on disease pathogenesis and progression, thus offering new insights into the diagnosis and treatment of this devastating and progressive disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following the successful use of FMT in the treatment of refractory or recurrent Clostridium difficile infection, several studies have been conducted to explore FMT as a therapeutic strategy for a wide range of neurological disorders, including multiple sclerosis, epilepsy, ASD, Tourette syndrome, diabetic neuropathy, AD and PD, with promising preclinical and clinical data [30,465,466,467,468].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Experimental — accuracy not yet measuredIn the citing paper
“GM-based biomarkers have recently been considered as promising early and prodromal diagnostic tools in various neurological diseases, such as multiple sclerosis, AD and PD itself [30,156,157]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“• Through incoming and outgoing branches of the vagus nerve [26], which represents the major modulatory pathway [27].”
BackgroundParada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820 · cited 1×
“As mentioned, another beneficial role exerted by the gut microbiota is the production of SCFAs, including butyrate, propionate, and acetate, essential for energy production, gut epithelia homeostasis, and immune regulation [83].”
BackgroundFormation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Although the composition of a “healthy microbiota” has not yet been defined, a balanced environment between the host and microorganisms is known to be essential to carry on the necessary immunological and metabolic functions [58].”
BackgroundPathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228 · cited 1×
“This alteration, in turn, may affect the CNS through the modulation of stress hormones [28].”
Background
Cited by
Communication of gut microbiota and brain via immune and neuroendocrine signaling
Kasarello, K., Cudnoch-Jedrzejewska, A., & Czarzasta, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1118529 · Cited by 247
“Moreover, numerous studies indicate a wellchosen diet as a quick way to modify the composition and metabolism of the gut microbiota, reduce inflammation, and help maintain eubiosis and proper dependencies in the gut-brain axis (Metta et al., 2022; Varesi et al., 2022).”
BackgroundResultUpdates in Alzheimer's disease: from basic research to diagnosis and therapies
Liu, E., Zhang, Y., & Wang, J.-Z. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 199
“The human gut harbors bacteria, viruses, and fungi [138].”
BackgroundAn Explainable AI Paradigm for Alzheimer’s Diagnosis Using Deep Transfer Learning
Mahmud, T., Barua, K., Habiba, S. U., Sharmen, N., Hossain, M. S., & Andersson, K. (2024) · Diagnostics · doi:10.3390/diagnostics14030345 · Cited by 167
“For feature extraction, by leveraging its ability to capture high-level features from input images, such as edges, textures, and shapes, we used EfficientNet as a feature extractor [1], where we realized a 6400 × 1280 feature matrix [33].”
MethodBlood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 139
“Though data are still inconclusive, gut bacteria family and genus shifts might represent promising tools as novel biomarkers for the diagnosis and progression of AD, and the restoration of gut microbiota balance a potential therapeutic approach [380].”
BackgroundSelf-citationBicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
“There is also some evidence that MCI and early-stage AD already show signs of pro-inflammatory bacteria increases, such as Escherichia/Shigella , in addition to increased inflammation [68].”
Borrego-Ruiz, A., & Borrego, J. J. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110861 · Cited by 122
Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration
Molinero, N., Antón‐Fernández, A., Hernández, F., Ávila, J., Bartolomé, B., & Moreno-Arribas, M. V. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.02.014 · Cited by 110
Brain modulation by the gut microbiota: From disease to therapy
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2022.12.001 · Cited by 91
“…between the gut and brain occurs via the gut– brain axis (GBA), a two-way signaling pathway connecting the gastrointestinal (GI) tract and CNS [6]; this consists of the immune system, vagus nerve, several neurotransmitters, hypothalamic–pit uitary–adrenal axis (HPA), bacterial metabolites,…”
BackgroundTargeting the Gut–Eye Axis: An Emerging Strategy to Face Ocular Diseases
Campagnoli, L. I. M., Varesi, A., Barbieri, A., Marchesi, N., & Pascale, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713338 · Cited by 99
“To date, FMT has been successfully used for the treatment of refractory or recurrent Clostridium difficile infections [238,239] and is now under consideration for primary Clostridium difficile infections [240], Crohn’s disease [241], intestinal bowel syndrome [242], chronic fatigue syndrome [243], obesity [244], neuro…”
BackgroundMethodSelf-citationVaresi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
“Similar to what has been reported in Alzheimer’s disease (AD) and aging [30], feces from PD patients are enriched in opportunistic pathogens and pro-inflammatory taxa at the expense of anti-inflammatory microbes and SCFAsproducing bacteria, especially butyrate [47–51].”
BackgroundResultSelf-citationThe brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches
Varesi, A., Campagnoli, L. I. M., Chirumbolo, S., Candiano, B., Carrara, A., Ricevuti, G., Esposito, C., & Pascale, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106799 · Cited by 94
Self-citationElangovan, S., Borody, T. J., & Holsinger, R. M. D. (2022) · Cells · doi:10.3390/cells12010119 · Cited by 75
Zhu, Z., Ma, X., Wu, J., Xiao, Z., Wu, W., Ding, S., Zheng, L., Liang, X., Luo, J., Ding, D., et al. (2022) · Nutrients · doi:10.3390/nu14193959 · Cited by 83
“against cognitive deterioration in Alzheimer’s disease [9,10].”
BackgroundMolecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders
Wu, C., Zou, P., Feng, S., Zhu, L., Li, F., Liu, T. C., Duan, R., & Yang, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03175-w · Cited by 73
“Similarly, endobacteria-produced hydrogen is fundamental for proper neuronal function, and the changes in endobacteria-produced hydrogen also contribute to AD pathogenesis [61].”
BackgroundXu, J., & Lu, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1583562 · Cited by 93
Kim, Y., Lim, J., & Oh, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117277 · Cited by 71
Gut microbiome-brain-cirrhosis axis
Smith, M. L., Wade, J. B., Wolstenholme, J. T., & Bajaj, J. S. (2023) · Hepatology · doi:10.1097/hep.0000000000000344 · Cited by 68
L., K., Ng, T. K. S., Wee, H. N., & Ching, J. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111787 · Cited by 58
“Varesi et al., outlines the different studies that explored variations of the mediterranean and ketogenic diets (e.g. Dietary Approaches to Stop Hypertension (DASH), Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets) (Varesi et al., 2022b).”
BackgroundInfluentialThe Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Ghezzi, L., Cantoni, C., Rotondo, E., & Galimberti, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071486 · Cited by 57
“Lastly, as outlined in the previous paragraph, strains of bacteria derived from the gut microbiome can produce amyloids and favor Aβ peptide aggregation [101].”
BackgroundResultInfluentialNovelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Popescu, C., Munteanu, C., Anghelescu, A., Ciobanu, V., Spînu, A., Andone, I., Mandu, M., Bistriceanu, R., Băilă, M., Postoiu, R.-L., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011272 · Cited by 63
“In older adults with AD, this microbial imbalance exacerbates the breakdown of the intestinal barrier, allowing LPS to translocate into circulation and reach the brain, intensifying inflammatory cascades that worsen neurodegeneration [33].”
BackgroundLipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
Zhao, Y., Jaber, V. R., Pogue, A. I., Sharfman, N. M., Taylor, C., & Lukiw, W. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012671 · Cited by 66
Metagenomic analysis characterizes stage-specific gut microbiota in Alzheimer’s disease
Jia, L., Ke, Y., Zhao, S., Liu, J., Luo, X., Cao, J., Liu, Y., Guo, Q., Chen, W., Chen, F., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02973-7 · Cited by 58
“Emerging evidence has revealed that gut microbiota is associated with AD pathology through the microbiota-gut-brain axis [15 – 17] and offers new insights into the diagnosis of preclinical AD [18].”
Montanari, M., Imbriani, P., Bonsi, P., Martella, G., & Peppe, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061560 · Cited by 53
Microglia and gut microbiota: A double-edged sword in Alzheimer's disease
Bano, N., Khan, S., Ahamad, S., Kanshana, J. S., Dar, N. J., Khan, S. J., Nazir, A., & Bhat, S. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102515 · Cited by 53
Ruggiero, C., Baroni, M., Xenos, D., Parretti, L., Macchione, I. G., Bubba, V., Laudisio, A., Pedone, C., Ferracci, M., Magierski, R., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102130 · Cited by 54
Sabarathinam, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-61779-9 · Cited by 49
“And also, the age-related gut microbiome imbalance increases the risk of bacteria circulation to the brain increasing the risk of inflammation and brain changes 35 .”
BackgroundPotentials of ionic liquids to overcome physical and biological barriers
Beaven, E., Kumar, R., An, J. M., Mendoza, H., Sutradhar, S. C., Choi, W., Narayan, M., Lee, Y.-K., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115157 · Cited by 47
Yan, L., Li, H., Qian, Y., Zhang, J., Cong, S., Zhang, X., Wu, L., Wang, Y., Wang, M., & Yu, T. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1334887 · Cited by 50
“This regulation is facilitated through a complex messaging system involving the central nervous system (CNS), autonomic nervous system (ANS), enteric nervous system (ENS), and the hypothalamus-pituitary–adrenal (HPA) axis (Varesi et al., 2022).”
BackgroundGut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease
Denman, C. R., Park, S. M., & Jo, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1268419 · Cited by 47
“These strategies have been reviewed in detail (Sun and Shen, 2018; Varesi et al., 2022).”
BackgroundUnveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics
Athanasopoulou, K., Adamopoulos, P. G., & Scorilas, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030827 · Cited by 51
“It is worth mentioning that Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, Streptococcus, Spirochaetes, Synergistetes, and Tenericutes are representative phyla that have been found in this highly complex bacteria community (Figure 1).”
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Borrego-Ruiz, A., & Borrego, J. J. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112497 · Cited by 47
Zhang, S., Lv, S., Li, Y., Wei, D., Zhou, X., Niu, X., Yang, Z., Song, W., Zhang, Z., & Peng, D. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03208-7 · Cited by 44
Yin, C., Zhang, M., Jin, S., Zhou, Y., Ding, L., Lv, Q., Huang, Z., Zhou, J., Chen, J., Wang, P., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155725 · Cited by 45
Ma, L., Jiang, X., Huang, Q.-Y., Chen, W., Zhang, H., Pei, H., Cao, Y., Wang, H., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115244 · Cited by 45
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
Reza-Zaldívar, E. E., & Jacobo‐Velázquez, D. A. (2023) · ACS Omega · doi:10.1021/acsomega.3c04855 · Cited by 47
Chen, M., Li, D., Meng, X., Sun, Y., Liu, R., & Sun, T. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128565 · Cited by 42
Zhang, Y., Wang, G., Li, R., Liu, R., Yu, Z., Zhang, Z., & Wan, Z. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2022.105459 · Cited by 37
Implications of Microorganisms in Alzheimer’s Disease
Yadav, P., Lee, Y., Panday, H., Kant, S., Bajwa, N., Parashar, R., Jha, S. K., Jha, N. K., Nand, P., Lee, S., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100314 · Cited by 40
“, Saccharomyces cerevisiae, and Penicillium may also be implicated in neurological disease [67].”
BackgroundMafe, A. N., & Büsselberg, D. (2025) · Foods · doi:10.3390/foods14091559 · Cited by 38
“Preclinical studies in animal models have shown that FMT can have beneficial effects on brain health, including improved memory, reduced amyloid plaque accumulation, and decreased neuroinflammation [170].”
Chatterjee, A., Kumar, S., Sarkar, S. R., Halder, R., Kumari, R., Banerjee, S., & Sarkar, B. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109622 · Cited by 39
Bacterial live therapeutics for human diseases
Frutos-Grilo, E., Ana, Y., Miguel, J. G.-D., Cardona-I-Collado, M., Rodríguez-Arce, I., & Serrano, L. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00067-0 · Cited by 39
“This shift contributes to GI permeability and neuroin fl ammation, driven by bacterial derivatives (LPS and bacterial amyloids) (Varesi et al, 2022; Hauss-Wegrzyniak et al, 2000).”
The Gut Microbiota-Brain Axis: A New Frontier on Neuropsychiatric Disorders
Queiroz, S. A. L., Ton, A. M. M., Pereira, T. D. M. C., Campagnaro, B. P., Martinelli, L., Picos, A., Campos‐Toimil, M., & Vasquez, E. C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.872594 · Cited by 37
From Gut to Eye: Exploring the Role of Microbiome Imbalance in Ocular Diseases
Tîrziu, A.-T., Șușan, M. M., Șușan, R. M., Sonia, T., Harich, O. O., Tudora, A. G., Varga, N.-I., Dragomir, T. L., Avram, C. R., Boru, C., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185611 · Cited by 40
“This targeted promotion has led to the exploration of prebiotics as preventive or therapeutic agents for various health problems, such as neurological disorders, cardiovascular and skin diseases, and Chron’s disease [102–105].”
BackgroundSlowing Alzheimer’s disease progression through probiotic supplementation
Medeiros, D., McMurry, K., Pfeiffer, M., Newsome, K., Testerman, T., Graf, J., Silver, A. C., & Sacchetti, P. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1309075 · Cited by 33
A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism
Matsuzaki, K., Nakajima, A., Guo, Y., & Ohizumi, Y. (2022) · Nutrients · doi:10.3390/nu14091847 · Cited by 33
Fecal Microbiota Transplantation Role in the Treatment of Alzheimer's Disease: A Systematic Review
Nassar, S. T., Tasha, T., Desai, A. V., Bajgain, A., Ali, A., Dutta, C., Pasha, K., Paul, S., Abbas, M. S., & Venugopal, S. (2022) · Cureus · doi:10.7759/cureus.29968 · Cited by 35
Zhan, Y., Al‐Nusaif, M., Ding, C., Zhao, L., & Dong, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1130730 · Cited by 34
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 33
“difficile infection (CDI), and is currently the most effective intervention for regulating GM (Surawicz et al., 2013; Varesi et al., 2022).”
BackgroundA metagenomic study of gut viral markers in amyloid-positive Alzheimer’s disease patients
Ghorbani, M., Ferreira, D., & Maioli, S. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01285-8 · Cited by 29
“In recent years, there has been an explosion of interest in the gut microbiota-brain axis, which has been suggested as a therapeutic target for central nervous system illnesses [10].”
BackgroundGiuffrè, M., Merli, N., Pugliatti, M., & Moretti, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063337 · Cited by 32
“…with different neurological conditions such as stroke, involvement in pathogenesis, potentially improving or worsening the prognosis of cerebrovascular events [113], mediating immunomodulatory therapy’s effects in multiple sclerosis [114], and contributions to AD pathogenesis and progression [115].”
BackgroundObesity, Cardiovascular and Neurodegenerative Diseases: Potential Common Mechanisms
Kuneš, J., Hojná, S., Mráziková, L., Montezano, A. C. I., Touyz, R. M., & Maletínská, L. (2023) · Physiological Research · doi:10.33549/physiolres.935109 · Cited by 34
Unveiling the neuroprotective potential of dietary polysaccharides: a systematic review
Guo, R., Pang, J., Zhao, J., Xiao, X., Li, J., Li, J., Wang, W., Zhou, S., Zhao, Y., Zhang, Z., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1299117 · Cited by 29
Ren, J., Wang, Q., Hong, H., & Tang, C. (2025) · Microorganisms · doi:10.3390/microorganisms13081956 · Cited by 30
Gut Microbiome in Alzheimer’s Disease: from Mice to Humans
Liang, C., Pereira, R., Zhang, Y., & Rojas, O. L. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240308090741 · Cited by 28
“Prebiotics, on the other hand, are described as nutrients that have been specifically fermented to cause specific changes in the composition and/or activity of the GM, bringing health advantages to the host [76, 108].”
BackgroundMechanistic insight of neurodegeneration due to micro/nano-plastic-induced gut dysbiosis
Ghosh, A., & Gorain, B. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03875-3 · Cited by 28
“In simpler terms, the gut microbiota's byproducts can influence gut cells and immune responses, potentially impacting hormonal pathways and immune activity in the CNS (Kennedy et al. 2017; Cryan et al. 2019; Morais et al. 2021; Varesi et al. 2022).”
Trisal, A., Singh, I., Garg, G., Jorwal, K., & Singh, A. K. (2024) · 3 Biotech · doi:10.1007/s13205-024-04187-0 · Cited by 32
“Numerous studies have demonstrated that dysbiosis is linked to the progression of Alzheimer’s disease and that a healthy microbiome can slow the progression of this disease (Varesi et al. 2022).”
The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans
Fabi, J. P. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01369-w · Cited by 28
Correlation between Alzheimer’s Disease and Gastrointestinal Tract Disorders
Kuźniar, J., Kozubek, P., Czaja, M., & Leszek, J. (2024) · Nutrients · doi:10.3390/nu16142366 · Cited by 27
“In symptomatic AD, a dysbiosis of the microflora relative to healthy individuals is evident In AD, a decrease in the diversity of the microbiome with a predominance of pro-in fl ammatory species is typical [12].”
BackgroundInfluentialImpact of diet and exercise on mitochondrial quality and mitophagy in Alzheimer's disease
Pradeepkiran, J. A., Islam, M. A., Sehar, U., Reddy, A. P., Vijayan, M., & Reddy, P. H. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102734 · Cited by 27
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Alves, S. S., Servilha‐Menezes, G., Rossi, L., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105326 · Cited by 27
The Gut Microbiome and Its Impact on Mood and Decision-Making: A Mechanistic and Therapeutic Review
Diotaiuti, P., Misiti, F., Marotta, G., Falese, L., Calabrò, G. E., & Mancone, S. (2025) · Nutrients · doi:10.3390/nu17213350 · Cited by 27
Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease
Peddinti, V., Avaghade, M. M., Suthar, S. U., Rout, B., Gomte, S. S., Agnihotri, T. G., & Jain, A. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.02.019 · Cited by 25
Lehoczki, A., Csípő, T., Lipécz, Á., Major, D., Fazekas‐Pongor, V., Csík, B., Mózes, N., Fehér, Á., Dósa, N., Árva, D., et al. (2025) · Nutrients · doi:10.3390/nu17152446 · Cited by 24
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?
Campagnoli, L. I. M., Marchesi, N., Varesi, A., Morozzi, M., Mascione, L., Ricevuti, G., Esposito, C., Galeotti, N., & Pascale, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107456 · Cited by 25
Self-citationOgunro, O. B. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151974 · Cited by 23
Exploring the potential of probiotics in Alzheimer's disease and gut dysbiosis
Sowmiya, S., Ls, D., Rajendran, P., Harikrishnan, N., & Ankul Singh, S. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.11.004 · Cited by 25
“Amyloid Beta (A β ) plaques and hyperphosphorylated tau neurofibrils slowly accumulate throughout the disease, causing neuroinflammation and a progressive loss of cognitive function (Varesi et al., 2022).”
A review on gut microbiota and miRNA crosstalk: implications for Alzheimer’s disease
Ayyanar, M. P., & Vijayan, M. (2024) · GeroScience · doi:10.1007/s11357-024-01432-5 · Cited by 25
“Modifying diets to address microbial dysbiosis offers a promising approach to mitigate AD-associated neurotoxic microbial substances such as LPS, potentially altering the disease’s course [250, 348, 351, 352].”
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
Dai, C., Liu, F., Iqbal, K., & Gong, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315230 · Cited by 25
“The primary function of the MGB axis is to monitor and integrate intestinal functions and to link, through immune and neuro-endocrine mediators, the emotional and cognitive centers of the brain to peripheral intestinal mechanisms, such as immune activation, intestinal permeability, enteric reflex, and entero-endocrine…”
BackgroundMicrobial Metabolomes in Alzheimer’s Disease: From Pathogenesis to Therapeutic Potential
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090724 · Cited by 22
“…respect, emerging evidence suggests that GM dysbiosis, which is characterized by shifts in microbial composition, reduced diversity, and altered functionality, may modulate neural circuits involved in cognitive decline and neurodegeneration [23,24], making it a key factor in AD pathology [25,26].”
Gut microbiota influence frailty syndrome in older adults: mechanisms and therapeutic strategies
Wang, X., Fan, L., Meng, C., Wang, Y., Deng, L.-E., Yuan, Z., Zhang, J., Li, Y., & Lv, S. (2023) · Biogerontology · doi:10.1007/s10522-023-10082-7 · Cited by 21
“The ecological dysregulation of gut microbiota is associated with the pathogenesis of several geronto-logical diseases such as Alzheimer’s disease, Parkinson’s disease, and so on (Keshavarzian et al. 2020; Varesi et al. 2022).”
Wei, S., Ma, X., Chen, Y., Wang, J., Hu, L., Liu, Z., Mo, L.-D., Zhou, N., Chen, W.-R., Zhu, H., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04579-6 · Cited by 21
“However, a study from China reported an enrichment of the Bacteroidetes phylum, specifically the Bacte-roidaceae family, in the gut microbiota of AD patients at the phylum and family levels [33].”
Lin, K., Lin, W., Guo, Z., Chen, C., Liang, C., & Cai, X. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1545690 · Cited by 21
“In AD patients, the diversity of gut microbiota shows a downward trend, and this change comes at the expense of anti-inflammatory probiotics, while leading to a significant increase in pro-inflammatory microflora (Varesi et al., 2022).”
New Insights into Photobiomodulation of the Vaginal Microbiome—A Critical Review
Santos, F., Carvalhos, C. A., & Figueiredo-Dias, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713507 · Cited by 21
Pasupalak, J. K., Rajput, P., & Gupta, G. L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177022 · Cited by 19
Wang, X., Xie, Z., Yuan, J., Jin, E., Lian, W., Chang, S., Sun, G., Feng, Z., Xu, H., Du, C., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00725-5 · Cited by 22
“For example, the alteration of butyrate-producing bacteria has been linked to T-cell imbalance, epithelial barrier leakage ( “ leaky gut ” ), and the increased bacterial translocation in AD 7 .”
Upadhyay, P., & Gupta, S. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114473 · Cited by 20
Role of short chain fatty acids on astrocytes and microglia in Alzheimer's disease brain
Wtpsk, S., Burton, M., Fernando, W. M. K. T., Jayasena, V., Brennan, C. S., & Fernando, W. M. A. D. B. (2024) · International Journal of Food Science & Technology · doi:10.1111/ijfs.17380 · Cited by 18
Que, M., Li, S., Qian, X., Li, X., Luo, X., Zhan, G., & Luo, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106627 · Cited by 19
Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
Panchal, S. K., & Brown, L. (2022) · Molecules · doi:10.3390/molecules28010080 · Cited by 19
Wang, J., Zhang, X., Yang, X., Yu, H., Bu, M.-M., Fu, J., Zhang, Z., Xu, H., Hu, J., Lu, J., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1191936 · Cited by 21
“, 2021), and neurological disorders (Varesi et al., 2022).”
Marizzoni, M., Mombelli, E., Alboni, S., Rosa, M., Moretti, D. V., Mirabelli, P., Coppola, L., Luongo, D., Salamone, D., Saleri, S., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106138 · Cited by 19
The role of the gut microbiota in neurodegenerative diseases targeting metabolism
Fu, Y., Gu, Z., Cao, H., Zuo, C., Huang, Y., Song, Y., Jiang, Y., & Wang, F. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1432659 · Cited by 18
Zhou, B., Ma, R., Wang, M., & Wang, Y. (2025) · BMC Public Health · doi:10.1186/s12889-025-22294-2 · Cited by 21
“This results in neuronal damage and reduced synaptic plasticity, directly compromising the cognitive domain of intrinsic capacity [31, 32].”
Yang, B., He, M., Chen, X., Sun, M., Pan, T., Xu, X., Zhang, X., Gong, Q., Zhao, Y., Jin, Z., et al. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/1527159 · Cited by 20
RetractedPogue, A. I., Jaber, V. R., Sharfman, N. M., Zhao, Y., & Lukiw, W. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.900048 · Cited by 17
John, D., Yalamarty, R., Barakchi, A., Chen, T., Chakladar, J., Li, W. T., & Ongkeko, W. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043148 · Cited by 17
“While early studies of the microbiome focused primarily on the interactions of gut flora with innate phenotypes [17,18], novel studies have characterized the microbiome as an important driver of various diseases, including inflammatory bowel disease (IBD) [19,20], arthritis [21,22], Alzheimer’s [23,24], diabetes [25,2…”
BackgroundMicrobiome Alterations and Alzheimer’s Disease: Modeling Strategies with Transgenic Mice
López-Villodres, J. A., Escamilla, A., Mercado-Sáenz, S., Alba-Tercedor, C., Rodríguez‐Pérez, L., Arranz‐Salas, I., Sanchez-Varo, R. M., & Bermúdez, D. (2023) · Biomedicines · doi:10.3390/biomedicines11071846 · Cited by 20
Periodontal Status and Saliva Metabolic Signature in Patients with Alzheimer’s Disease
Yang, Y., Lv, J., Bai, H., Ren, L., Yang, J. Y., Ding, Y., Liu, C., & Chen, X. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230291 · Cited by 17
Mo, Y., He, X., Cui, H., Cheng, Y., Zhou, M., Cui, X., & Zhang, T. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119306 · Cited by 17
Guo, X., Zhang, X., Tang, P., Li, C., & Li, R. (2023) · Age and Ageing · doi:10.1093/ageing/afad112 · Cited by 16
Advances of therapy for Alzheimer's disease: An updated review
Mei, C., Zhan, J., Zhu, S., Zhang, Y., Xiong, C., Wang, J., Xu, Y. J., Zhong, H., & Cheng, J. (2024) · Brain‐X · doi:10.1002/brx2.68 · Cited by 16
Mechanism of Metal Complexes in Alzheimer’s Disease
Yi, L. I. U., Ma, J., Zhang, Q., Wang, Y., & Sun, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211873 · Cited by 18
Oral Health and Cognitive Decline: A Systematic Review of the Periodontitis–Alzheimer’s Connection
Inchingolo, A. M., Inchingolo, A. D., Piras, F., Avantario, P., Ferrante, L., Paduanelli, G., Inchingolo, F., Palermo, A., Dipalma, G., & Corsalini, M. (2025) · Applied Sciences · doi:10.3390/app15126728 · Cited by 18
Sip, S., Rosiak, N., Sip, A., Żarowski, M., Hojan, K., & Cielecka‐Piontek, J. (2023) · Antioxidants · doi:10.3390/antiox13010024 · Cited by 18
Nazir, M. M., Ghaffar, W., Mustafa, G., Saeed, S., Ijaz, M. U., & Ashraf, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04464-6 · Cited by 15
“While bacteria from the Firmicutes phylum produce a lot of butyrate in the human gut, those from the Bacteroidetes phylum secrete a lot of acetate and propionate (Varesi et al. 2022).”
Crohn’s Disease Prediction Using Sequence Based Machine Learning Analysis of Human Microbiome
Ünal, M., Bostancı, E., Özkul, C., Açıcı, K., Aşuroğlu, T., & Güzel, M. S. (2023) · Diagnostics · doi:10.3390/diagnostics13172835 · Cited by 14
“Microbiota refers to the community of numerous microorganisms, including viruses, bacteria, and fungi, that use the human body as a host [3].”
BackgroundElevated Aβ aggregates in feces from Alzheimer’s disease patients: a proof-of-concept study
Pils, M., Dybala, A., Schaffrath, A., Rehn, F., Kutzsche, J., Blömeke, L., Tusche, M., Özdüzenciler, P., Bujnicki, T., Kraemer‐Schulien, V., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01597-3 · Cited by 15
“Recent studies have demonstrated that microbiome composition and species richness change during AD progression and might impact cognition [6, 7, 37, 38].”
BackgroundAziz, N., Wal, P., Patel, A., & Prajapati, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03109-4 · Cited by 13
“Additionally, studies have shown that AD is associated with higher permeability of the intes-tines and decreased gram-negative organisms’ abundance (Varesi et al. 2022).”
Ngah, W. Z. W., Ahmad, H. F., Ankasha, S. J., Makpol, S., & Tooyama, I. (2024) · Antioxidants · doi:10.3390/antiox13121504 · Cited by 13
Gastrointestinal Dysfunction in Neurological and Neurodegenerative Disorders
Raber, J., & Sharpton, T. J. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771459 · Cited by 16
Metadata
- Authors
- Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., & Pascale, A.
- Affiliations
- University of Pavia (IT)
- University of Lancashire (GB)
- Université Libre de Bruxelles (BE)
- Policlinico San Matteo Fondazione (IT)
- Council for Nutritional and Environmental Medicine (NO)
- University of Verona (IT)
- Corresponding author
- Varesi, Angelica
- Ricevuti, Giovanni
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-02-05
- Volume
- 14
- Issue
- 3
- Pages
- 668
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8840394
- OpenAlex
- W4210475085
- Cited by
- 225
- References
- 248
- Citations by year
- 2026: 24 · 2025: 54 · 2024: 68 · 2023: 53 · 2022: 26
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion, other-oa)
- Funders
- Università degli Studi di Pavia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- gut microbiota, Alzheimer's disease, gut-brain axis, dysbiosis, neurodegeneration, microbiota-based therapy, prebiotics, probiotics, fecal microbiota transplantation, diet, early diagnosis, disease progression
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Alzheimer Disease, Humans, Prebiotics, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.